William Grossman's Net Worth
$774 Thousand
Who is William Grossman?
William Grossman does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Arcus Biosciences, Inc., BELLICUM PHARMACEUTICALS, INC, and Day One Biopharmaceuticals, Inc..
SEC CIK
William Grossman's CIK is 0001730229
Past Insider Trading and Trends
2020 was William Grossman's most active year for acquiring shares with 6 total transactions. William Grossman's most active month to acquire stocks was the month of December. 2021 was William Grossman's most active year for disposing of shares, totalling 5 transactions. William Grossman's most active month to dispose stocks was the month of May. 2020 saw William Grossman paying a total of $1,703,944.56 for 395,200 shares, this is the most they've acquired in one year. In 2021 William Grossman cashed out on 13,325 shares for a total of $372,969.59, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arcus Biosciences, Inc. (RCUS) Snapshot price: $15.72
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -25.42% | -7.07K |
$23.89 | -$168,808.78 | 20.72K |
Jun 16 - Jun 17
| |||
Form 4
| -38.09% | -4.13K |
$31.37 | -$129,652.21 | 6.72K |
Apr 23
| |||
Form 4
| -16.39% | -2.13K |
$35.03 | -$74,508.60 | 10.85K |
Mar 16
| |||
Form 4
| +278.73% | 18.75K |
—
|
—
| 25.48K |
Jan 19
| |||
Form 4
| -23.94% | -2.12K |
$31.35 | -$66,367.95 | 6.73K |
Dec 16
| |||
Form 4
| +16,666.67% | 100K |
—
|
—
| 100.6K |
Oct 2
| |||
Form 4
| +50.00% | 200 |
$19.72 | $3,944.56 | 600 |
Jul 31
| |||
Form 4
| +13,750.00% | 55K |
—
|
—
| 55.4K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
∞
| 400 |
$8.00 | $3,200.00 | 400 |
Oct 10 - Oct 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BELLICUM PHARMACEUTICALS, INC (BLCM) Snapshot price: $0.2
Sr. VP, Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.42% | -3.13K |
$3.48 | -$10,878.48 | 26.87K |
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $13.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||